<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=AKERS_BIOSCIENCES_INC</id>
	<title>AKERS BIOSCIENCES INC - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=AKERS_BIOSCIENCES_INC"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=AKERS_BIOSCIENCES_INC&amp;action=history"/>
	<updated>2026-04-14T06:59:14Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=AKERS_BIOSCIENCES_INC&amp;diff=405603&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei AKERS BIOSCIENCES INC listata cu simbolul US.AKER  ==Descriere companie== MyMD Pharmaceuticals, Inc. (www.ir.mymd.com), formerly Akers Biosciences, Inc., is a clinical stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, includi...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=AKERS_BIOSCIENCES_INC&amp;diff=405603&amp;oldid=prev"/>
		<updated>2024-09-18T13:36:30Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei AKERS BIOSCIENCES INC listata cu simbolul US.AKER  ==Descriere companie== MyMD Pharmaceuticals, Inc. (www.ir.mymd.com), formerly Akers Biosciences, Inc., is a clinical stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, includi...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei AKERS BIOSCIENCES INC listata cu simbolul US.AKER&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
MyMD Pharmaceuticals, Inc. (www.ir.mymd.com), formerly Akers Biosciences, Inc., is a clinical stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. MyMD-1 is being developed to treat age-related illnesses such as frailty and sarcopenia. MyMD-1 works by regulating the release of numerous pro-inflammatory cytokines, such as TNF-Î±, interleukin 6 (IL-6) and interleukin 17 (IL-17). Supera-CBD is a synthetic derivative of Cannabidiol (CBD) being developed to treat various conditions, including, but not limited to, epilepsy, pain and anxiety or depression.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.AKER&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre AKERS BIOSCIENCES INC (US.AKER)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.AKER&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.AKER]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>